FIELD: organic chemistry.
SUBSTANCE: present invention relates to the compound of Formula (I):
(I),
or its pharmacologically acceptable salts, a stereoisomer, or a tautomer, wherein radicals R1, R2, RA1, RA2, RC, RB, C, X1 are defined in the claim. A pharmaceutical composition is also proposed, a set for use in the treatment of a disease associated with a bromodomain-containing protein and/or with a bromodomain, methods for treating diseases associated with aberrant bromodomain activity, a method for male contraception, methods for inhibiting the activity of a bromodomain in a biological sample, methods for inhibiting binding of a bromodomain-containing protein to an acetyl-lysine residue of a second protein in a subject, methods for inhibiting gene expression, methods for inducing apoptosis, methods for inducing G1 blocking in a cell.
EFFECT: obtaining new organic compounds, which may be agents that have ability to bind bromodomain-containing proteins, and may be suitable for treatment of diseases associated with the activity of bromodomain-containing proteins.
78 cl, 1 dwg, 5 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
BIVALENT BROMODOMAIN INHIBITORS AND ROUTES OF USE THEREOF | 2016 |
|
RU2742035C2 |
DIHYDROPTERIDINONE DERIVATIVES AND USES THEREOF | 2015 |
|
RU2673944C2 |
NEUROACTIVE COMPOUNDS AND THEIR APPLICATION METHODS | 2015 |
|
RU2764702C2 |
VET PROTEIN DECOMPOSERS | 2017 |
|
RU2752677C2 |
NEUROACTIVE STEROIDS AND METHODS OF THEIR USE | 2014 |
|
RU2808166C2 |
BORONIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE | 2017 |
|
RU2773346C2 |
NEUROACTIVE STEROIDS SUBSTITUTED AT POSITION 10 WITH A CYCLIC GROUP FOR USE IN THE TREATMENT OF CNS DISORDERS | 2019 |
|
RU2796006C2 |
NEUROACTIVE STEROIDS, COMPOSITIONS AND THEIR USE | 2012 |
|
RU2808165C2 |
NEUROACTIVE STEROIDS AND METHODS FOR USE THEREOF | 2014 |
|
RU2684103C2 |
OXYSTEROLES AND METHODS OF USING THEM | 2016 |
|
RU2744267C2 |
Authors
Dates
2021-06-22—Published
2016-09-09—Filed